Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene
We report definitive diagnosis and effective treatment with oral cholic acid in one Italian male child affected by 3β- hydroxy-Δ5-C27-steroid dehydrogenase (3β- HSD) deficiency. He presented with failure to thrive, hepatomegaly and multiple cystic images in kidneys; no biochemical evidence of choles...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Pediatric Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/pr/article/view/7266 |
id |
doaj-d507e7c3570c4ba2b5fa25a92937ab8c |
---|---|
record_format |
Article |
spelling |
doaj-d507e7c3570c4ba2b5fa25a92937ab8c2021-01-02T14:10:19ZengMDPI AGPediatric Reports2036-749X2036-75032017-10-019310.4081/pr.2017.72663809Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 geneGrazia Bossi0Giuseppe Giordano1Gaetana Anna Rispoli2Giuseppe Maggiore3Mauro Naturale4Daniela Marchetti5Maria Iascone6Pediatric Department, IRCCS Foundation Policlinico San Matteo, PaviaMass Spectrometry Laboratory, Women’s and Children’s Health Department, University of Padua, Institute for Pediatric Research (IRP), PaduaDepartment of Radiology, US Pediatric Radiology, IRCCS Foundation Policlinico San Matteo, PaviaDepartment of Medical Science, Pediatric Section, University of FerraraMass Spectrometry Laboratory, Women’s and Children’s Health Department, University of Padua, Institute for Pediatric Research (IRP), PaduaLaboratory of Genetic Medicine, ASST Papa Giovanni XXIII, BergamoLaboratory of Genetic Medicine, ASST Papa Giovanni XXIII, BergamoWe report definitive diagnosis and effective treatment with oral cholic acid in one Italian male child affected by 3β- hydroxy-Δ5-C27-steroid dehydrogenase (3β- HSD) deficiency. He presented with failure to thrive, hepatomegaly and multiple cystic images in kidneys; no biochemical evidence of cholestasis. Large amounts of bile acid metabolites was detected in urine by fast atom bombardment ionization mass spectrometry (FAB-MS). <em>HSDH3B7</em> gene analysis identified one mutation in intron 4, at nucleotide 432, G>A substitution that has never been reported before.The replacement therapy with oral cholic acid started early after the diagnosis and is still ongoing. Three years later hepatomegaly is no longer evident, liver function is normal and the child is growing regularly. In our experience, clinical features of 3β-HSD deficiency can be very poor and even cholestasis can lack at diagnosis. Early replacement therapy with cholic acid is safe and leads to clinical and biochemical control of the disease.http://www.pagepress.org/journals/index.php/pr/article/view/7266genetic cholestasischolic acid |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Grazia Bossi Giuseppe Giordano Gaetana Anna Rispoli Giuseppe Maggiore Mauro Naturale Daniela Marchetti Maria Iascone |
spellingShingle |
Grazia Bossi Giuseppe Giordano Gaetana Anna Rispoli Giuseppe Maggiore Mauro Naturale Daniela Marchetti Maria Iascone Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene Pediatric Reports genetic cholestasis cholic acid |
author_facet |
Grazia Bossi Giuseppe Giordano Gaetana Anna Rispoli Giuseppe Maggiore Mauro Naturale Daniela Marchetti Maria Iascone |
author_sort |
Grazia Bossi |
title |
Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene |
title_short |
Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene |
title_full |
Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene |
title_fullStr |
Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene |
title_full_unstemmed |
Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene |
title_sort |
atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the hsd3b7 gene |
publisher |
MDPI AG |
series |
Pediatric Reports |
issn |
2036-749X 2036-7503 |
publishDate |
2017-10-01 |
description |
We report definitive diagnosis and effective treatment with oral cholic acid in one Italian male child affected by 3β- hydroxy-Δ5-C27-steroid dehydrogenase (3β- HSD) deficiency. He presented with failure to thrive, hepatomegaly and multiple cystic images in kidneys; no biochemical evidence of cholestasis. Large amounts of bile acid metabolites was detected in urine by fast atom bombardment ionization mass spectrometry (FAB-MS). <em>HSDH3B7</em> gene analysis identified one mutation in intron 4, at nucleotide 432, G>A substitution that has never been reported before.The replacement therapy with oral cholic acid started early after the diagnosis and is still ongoing. Three years later hepatomegaly is no longer evident, liver function is normal and the child is growing regularly. In our experience, clinical features of 3β-HSD deficiency can be very poor and even cholestasis can lack at diagnosis. Early replacement therapy with cholic acid is safe and leads to clinical and biochemical control of the disease. |
topic |
genetic cholestasis cholic acid |
url |
http://www.pagepress.org/journals/index.php/pr/article/view/7266 |
work_keys_str_mv |
AT graziabossi atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT giuseppegiordano atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT gaetanaannarispoli atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT giuseppemaggiore atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT mauronaturale atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT danielamarchetti atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene AT mariaiascone atypicalclinicalpresentationandsuccessfultreatmentwithoralcholicacidofachildwithdefectivebileacidsynthesisduetoanovelmutationinthehsd3b7gene |
_version_ |
1724353553218142208 |